Search results
Biogen (BIIB) Stock Down Despite FDA Nod to Alzheimer's Drug
Zacks via Yahoo Finance· 10 months agoBiogen’s BIIB stock was down on Friday despite FDA’s long-awaited full approval to its and partner...
Biogen (BIIB), Eisai's Lecanemab Gets FDA Nod for Alzheimer's
Zacks via Yahoo Finance· 1 year agoFDA approves Biogen (BIIB) and Eisai's lecanemab on an accelerated basis. Eisai filed a supplemental...
Biogen (BIIB) Down on Report of Death in Alzheimer's Study
Zacks via Yahoo Finance· 1 year agoInvestor confidence in Biogen (BIIB) is rattled following reports of a study participant's death who...
Biogen Inc. (BIIB) Up 4.7% Since Last Earnings Report: Can It Continue?
Zacks via Yahoo Finance· 12 months agoA month has gone by since the last earnings report for Biogen Inc. (BIIB). Shares have added about...
Biotech Stock Roundup: BIIB's AD Drug Data & REGN, IONS, VRTX's Updates
Zacks via Yahoo Finance· 2 years agoIt has been a busy week for the biotech companies, with drug approvals and other regulatory news...
Biotech Stock Roundup: BIIB, Eisai's Drug Update, NVAX Gains on Deal Amendment
Zacks via Yahoo Finance· 10 months agoIt was a busy week for the biotech sector, with many important regulatory and pipeline updates....
Biotech Stock Roundup: BIIB & BMY's Q3 Earnings, TCDA Down on Study Update
Zacks via Yahoo Finance· 2 years agoEarnings results, along with important regulatory and pipeline updates, continue to keep the biotech...
Biotech Stock Roundup: BIIB's Q4 Results, CBAY Up on GILD's Acquisition & Other Updates
Zacks via Yahoo Finance· 3 months agoIt has been a busy week for the biotech sector, with earnings results. Biogen BIIB reported...
Does This Signal Trouble for Biogen's New Alzheimer's Drug?
Motley Fool· 11 months agoBiogen (NASDAQ: BIIB) recently got some good news in the U.S. An advisory committee for the Food and...
We Think Biogen (NASDAQ:BIIB) Can Stay On Top Of Its Debt
Simply Wall St. via Yahoo Finance· 1 year agoLegendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is...